{
    "Trade/Device Name(s)": [
        "iBGStar Blood Glucose Monitoring System",
        "iBGStar Diabetes Manager Application",
        "BGStar Test Strips",
        "BGStar Control Solutions"
    ],
    "Submitter Information": "AgaMatrix, Inc.",
    "510(k) Number": "K103544",
    "Predicate Device Reference 510(k) Number(s)": [
        "K071393",
        "K101597"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGA",
        "NBW",
        "JJX",
        "JQP"
    ],
    "Summary Letter Date": "November 23, 2011",
    "Summary Letter Received Date": "November 25, 2011",
    "Submission Date": "December 5, 2011",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1660",
        "21 CFR 862.2100"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Whole Blood",
        "Capillary blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "iBGStar Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Glucose oxidase enzymatic method"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Application",
        "Test Strip",
        "Control Solution",
        "Software",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for AgaMatrix iBGStar Blood Glucose Monitoring System and Diabetes Manager Application for quantitative glucose measurement and data management.",
    "Indications for Use Summary": "For quantitative measurement of blood glucose in fresh capillary whole blood samples by people with diabetes at home, not for diagnosis or neonatal use; Diabetes Manager Application enables review and management of glucose data.",
    "fda_folder": "Clinical Chemistry"
}